|
|
|
| home > ebr > summer 2003 > the potential of zinc ions for prophylaxis and treatment of severe acute respiratory syndrome (sars) |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
The discovery that SARS is caused by a coronavirus, related to a group of viruses causing the common cold, may be significant in relation to evidence that zinc ions provide a natural protective mechanism against viruses - especially those such as rhinoviruses that cause respiratory tract infections. The effect of zinc is multi-factorial and is based on direct antiviral effects of zinc ions; amplification and maintenance of immunity; augmentation of interferon activity; and a natural defence mechanism at the cell membrane level. It is suggested that the SARS virus be tested for sensitivity to zinc ions. Because zinc deficiency is a worldwide public health problem, it is worth considering zinc supplementation as a prophylactic and therapeutic measure in the SARS outbreak. In order to maximise zinc absorption and possible local zinc ion action in the buccal cavity, it is suggested that the supplementation should be in the form of 9 to 15mg strength zinc lozenges designed to release divalent zinc ions.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BioPartnering North America™
26-28 February 2012, Vancouver Convention Centre, Vancouver, BC, Canada
BioPartnering North America 2012 (BPN) in Vancouver, Canada brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
More info >> |
|
 |
News and Press Releases |
 |
Pantec Biosolutions Showcases P.L.E.A.S.E.® Professional at the IMCAS Annual Congress
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will present its recently launched P.L.E.A.S.E.® Professional laser device at the International Master Course on Aging Skin (IMCAS) from 26th-29th January 2012 in Paris, France.
More info >> |
|
|
